Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 1, 2021
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
[ Fri, Oct 01st 2021
] - WOPRAI
Thu, September 30, 2021
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
[ Thu, Sep 30th 2021
] - WOPRAI
Kalpit Patel Initiated (BCYC) at Strong Buy and Held Target at $56 on, Sep 30th, 2021
Kalpit Patel of B. Riley Securities, Initiated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $56 on, Sep 30th, 2021.
Kalpit has made no other calls on BCYC in the last 4 months.
There is 1 other peer that has a rating on BCYC. Out of the 1 peers that are also analyzing BCYC, 0 agree with Kalpit's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kalpit
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Thursday, July 15th, 2021
